参考文献/References:
[1]Di Spiezio S A, Calagna G, Scognamiglio M, et al Prevention of intrauterine post-surgical adhesions in hysteroscopy. A systematic review [J]. Eur J Obstet Gynecol Reprod Biol,2016,203(5):182-192.
[2]DALTON V K, SAUNDERS N A, HARRIS L H, et al. Intrauterine adhesions after manual vacuum aspiration for early pregnancy failure [J]. Fertility and Sterility, 2006, 85(6): 1823.e1-1823.e3.
[3]YU Dan, WONG Y M, CHEONG Y, et al. Asherman syndrome--one century later [J]. Fertility and Sterility, 2008, 89(4): 759-779.
[4]SCHENKER J G, MARGALIOTH E J. Intrauterine adhesions: an updated appraisal [J]. Fertility and Sterility, 1982, 37(5): 593-610.
[5]HOOKER A B, LEMMERS M, THURKOW A L, et al. Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and longterm reproductive outcome [J]. Human Reproduction Update, 2014, 20(2): 262-278.
[6]DEANS R, ABBOTT J. Review of intrauterine adhesions [J]. Journal of Minimally Invasive Gynecology, 2010, 17(5): 555-569.
[7]The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, mullerian anomalies and intrauterine adhesions [J]. Fertil Steril,1988,49(6):944-955.
[8]KAMATO D, BURCH M L, PIVA T J, et al. Transforming growth factor-beta signalling: role and consequences of Smad linker region phosphorylation [J]. Cellular Signalling, 2013, 25(10): 2017-2024.
[9]MCGOWAN S E, MCNAMER R. Transforming growth factor-beta increases elastin production by neonatal rat lung fibroblasts [J]. American Journal of Respiratory Cell and Molecular Biology, 1990, 3(4): 369-376.
[10]GLEIZES P E, MUNGER J S, NUNES I, et al. TGF-beta latency:biological significance and mechanisms of activation [J]. Stem Cells, 1997, 15(3): 190-197.
[11]ANDRIEUX G, FATTET L, LE BORGNE M, et al. Dynamic regulation of Tgf-B signaling by Tif1gamma:a computational approach [J]. PLOS One, 2012, 7(3): e33761.
[12]MURO A F, MORETTI F A, MOORE B B, et al. An essential role for fibronectin extra type III domain A in pulmonary fibrosis [J]. American Journal of Respiratory and Critical Care Medicine, 2008, 177(6): 638-645.
[13]OVERALL C M W J, POST-TRANSCRIPTIONAL R F. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression [J]. Journal of Biological Chemistry, 1991, 266(21): 14064-14071.
[14]YU Q, STAMENKOVIC I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis [J]. Genes & Development, 2000, 14(2): 163-176.
[15]BORDER W A, NOBLE N A. Transforming growth factor beta in tissue fibrosis [J]. New England Journal of Medicine, 1994, 331(19): 1286-1292.
[16]BLOBE G C, SCHIEMANN W P, LODISH H F. Role of transforming growth factor beta in human disease [J]. New England Journal of Medicine, 2000, 342(18): 1350-1358.
[17]WATANABE Y, ITOH S, GOTO T, et al. TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling [J]. Molecular Cell, 2010, 37(1): 123-134.
[18]BAI Xi-long, JING Lei, LI Yin-chuan, et al. TMEPAI inhibits TGF-beta signaling by promoting lysosome degradation of TGF-beta receptor and contributes to lung cancer development [J]. Cellular Signalling, 2014, 26(9): 2030-2039.
[19]Vo Thanh Thao Nguyen, WATANABE Y, SHIBA A, et al. TMEPAI/PMEPA1 enhances tumorigenic activities in lung cancer cells [J]. Cancer Science, 2014, 105(3): 334-341.
[20]SHARAD S, RAVINDRANATH L, HAFFNER M C, et al. Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer [J]. Epigenetics, 2014, 9(6): 918-927.
[21]FOURNIER P G, JUAREZ P, JIANG G A, et al. The TGF-beta Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone [J]. Cancer Cell, 2015, 27(6): 809-821.